A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome.

Mohrland, J S

A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome. [electronic resource] - Annals of the rheumatic diseases Nov 1985 - 754-60 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

0003-4967

10.1136/ard.44.11.754 doi


Adult
Alprostadil--adverse effects
Blood Pressure--drug effects
Clinical Trials as Topic
Double-Blind Method
Female
Humans
Male
Middle Aged
Random Allocation
Raynaud Disease--drug therapy
Scleroderma, Systemic--complications
Severity of Illness Index
Skin Temperature--drug effects